Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?

Yannick Palmowski, Maarten Boers, Frank Buttgereit

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalArthritis Care & Research
DOIs
Publication statusE-pub ahead of print - 26 Oct 2017

Cite this

@article{b7e1e3c836ce4ba38d82c2522e6abd4a,
title = "Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?",
abstract = "We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.",
keywords = "Journal Article",
author = "Yannick Palmowski and Maarten Boers and Frank Buttgereit",
note = "This article is protected by copyright. All rights reserved.",
year = "2017",
month = "10",
day = "26",
doi = "10.1002/acr.23452",
language = "English",
journal = "Arthritis Care & Research",
issn = "2151-464X",
publisher = "John Wiley and Sons Inc.",

}

Low-dose glucocorticoids in rheumatoid arthritis : blurring the line between therapeutic dose and substitution therapy? / Palmowski, Yannick; Boers, Maarten; Buttgereit, Frank.

In: Arthritis Care & Research, 26.10.2017.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Low-dose glucocorticoids in rheumatoid arthritis

T2 - blurring the line between therapeutic dose and substitution therapy?

AU - Palmowski, Yannick

AU - Boers, Maarten

AU - Buttgereit, Frank

N1 - This article is protected by copyright. All rights reserved.

PY - 2017/10/26

Y1 - 2017/10/26

N2 - We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.

AB - We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.

KW - Journal Article

U2 - 10.1002/acr.23452

DO - 10.1002/acr.23452

M3 - Article

JO - Arthritis Care & Research

JF - Arthritis Care & Research

SN - 2151-464X

ER -